All the latest articles & insight from our investment writers to inspire your own research and analysis.
Bruce looks at WISE and AFX, currency traders that are benefiting from the market volatility and rising interest rates. He compares their investment case to the UK banks reporting this week. Despite all the volatility of the last week, the FTSE 100 was actually flat at 6,937 over the last 5 days. The Nasdaq100 and
We’re not alone – if it makes you feel better. Look at the Americans. Of course, you could argue that the market will help when rates are rising according to history: It’s no secret that inflation can have a significant impact on your portfolio. During times of high inflation, it can be difficult to maintain
A few weeks ago, I dug up a statistic that genuinely took my breath away. It came from VC-oriented asset manager Sparkline Capital – “Of the 1,495 US venture deals in the first half of the year, only 4.9% have been down rounds – a historical low!” My own view is that we are only in
Difficult markets prompt Maynard Paton to search for asset-rich shares with depressed ratings. Screening for low price to books and net cash positions leads to house builder Redrow. Difficult market conditions have led to depressed ratings for many asset-flush shares. Hence a new screen to pinpoint companies offering cash-rich balance sheets and market caps below
Two very different US financial personalities believe that US interest rates are rising too fast. No doubt bankers and fund managers are talking their own book, but that doesn’t mean they’re wrong. Stocks covered AT., BDEV, DARK The FTSE 100 failed to consolidate above 7,000 and was down -3.8% last week. The Nasdaq100 was down
Michael looks at several academic studies covering retail investors and what we can learn from them. We last looked at an academic article on trading in the summer of 2020. For a refresher, there were several findings. 1. “Retail investors tend to trade as contrarians after large earnings surprises, both positive and negative” Retail investors
Richard takes a first look at Dechra Pharmaceuticals, a company that has grown profit at a compound annual growth rate of 19% since 2013, yet its share price has halved this year. The financial year ending in June 2022, was Dechra Pharmaceuticals’ 25th anniversary. It was also the year the company joined the FTSE-100 index,
Welcome back to our monthly examination of listings on the London Stock Exchange. This time, we will be introducing three companies, namely: Fintech Asia Limited Ikigai Ventures Limited Sondrel (Holdings) plc Fintech Asia Limited Opening Date: 15th Sep 2022 Issue Price: 50p Market Cap: £10.37m Ticker: FINA At the helm: Oliver Fox CEO of Fintech
Bruce updates a chart Terry Smith first published in the FT in 2014, looking at Tesco EPS progress versus declining Return on Capital. Other companies featured IPX, SDRY, GRG and AGFX. The FTSE 100 recovered to just above 7000 last week and the pound recovered to 1.12 to the dollar. The Nasdaq100 and S&P500
Elric looks at the market trend for EVs, the ever-changing battery technology, battery options, and more. The problems ahead are a far more complex and endeavour than one may imagine, making it a tricky area for investors to navigate. Regular readers will be aware I have written at length on the Electric Vehicle (EV) transition
Bruce looks at the performance of large cap sectors YTD, and suggests rules of thumb for trying to time the turn in different sectors. Companies covered NFC, ASY, SMV, BGO and BOKU. The FTSE 100 was down -3.3% last week, falling below the 7,000 level. The S&P and Nasdaq100 were both down -1.3%. The UK
Michael looks at The 90% Club from 2021 and how to avoid getting caught by overpriced IPOs. Warren Buffett doesn’t like IPOs. In fact, this is what he said about them: “An IPO is like a negotiated transaction – the seller chooses when to come public – and it’s unlikely to be a time that’s favourable to
